Literature DB >> 2745702

Clinical, microbiological, and experimental animal studies of Candida lipolytica.

T J Walsh1, I F Salkin, D M Dixon, N J Hurd.   

Abstract

Candida lipolytica was recovered from six patients in three different clinical centers. The index isolate caused a persistent fungemia with catheter-associated Candida thrombophlebitis, the second isolate was from a polymicrobial sinusitis, and the remaining four isolates were involved in tissue colonization. These and 20 other isolates were consistent in their morphological and physiological characteristics. All formed true hyphae and blastoconidia on cornmeal-Tween 80 agar and all assimilated glucose, glycerol, and erythritol. In a murine model of disseminated candidiasis, the index isolate that caused clinical fungemia caused no mortality and produced only two lesions on a kidney, as determined at necropsy. The nine isolates selected for in vitro antifungal susceptibility studies had intermediate susceptibilities to amphotericin B but were susceptible to ketoconazole. We conclude that C. lipolytica is a weakly virulent pathogen which may require an intravascular foreign body to cause fungemia.

Entities:  

Mesh:

Year:  1989        PMID: 2745702      PMCID: PMC267456          DOI: 10.1128/jcm.27.5.927-931.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  [3 cases of ocular candidiasis caused by Candida lipolytica].

Authors:  V Nitzulescu; M Niculescu
Journal:  Arch Roum Pathol Exp Microbiol       Date:  1976-07

2.  Improved method for azole antifungal susceptibility testing.

Authors:  M A Gordon; E W Lapa; P G Passero
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

3.  [Report of a case of Yarrowia lipolytica (Wickerman et al.) van der Walt & von Arx isolated from a blood culture].

Authors:  P Wehrspann; U Füllbrandt
Journal:  Mykosen       Date:  1985-05

4.  Detection of yeasts and filamentous fungi in blood cultures during a 10-year period (1972 to 1981).

Authors:  J Bille; L Stockman; G D Roberts
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

5.  Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy.

Authors:  R Horn; B Wong; T E Kiehn; D Armstrong
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

6.  Candida septic thrombosis of the great central veins associated with central catheters. Clinical features and management.

Authors:  W D Strinden; R B Helgerson; D G Maki
Journal:  Ann Surg       Date:  1985-11       Impact factor: 12.969

7.  Paecilomyces lilacinus (Thom) Samson, from systemic infection in an armadillo (Dasypus novemcinctus).

Authors:  M A Gordon
Journal:  Sabouraudia       Date:  1984

8.  Pharmacokinetics and adverse effects of amphotericin B in infants and children.

Authors:  G Koren; A Lau; J Klein; C Golas; M Bologa-Campeanu; S Soldin; S M MacLeod; C Prober
Journal:  J Pediatr       Date:  1988-09       Impact factor: 4.406

9.  Detection of yeast septicemia by biphasic and radiometric methods.

Authors:  E Prevost; E Bannister
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

10.  Radiometric detection of yeasts in blood cultures of cancer patients.

Authors:  R L Hopfer; A Orengo; S Chesnut; M Wenglar
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

View more
  9 in total

Review 1.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Clinical Characteristics, Laboratory Identification, and In Vitro Antifungal Susceptibility of Yarrowia (Candida) lipolytica Isolates Causing Fungemia: a Multicenter, Prospective Surveillance Study.

Authors:  Ying Zhao; Jasper Fuk-Woo Chan; Chi-Ching Tsang; He Wang; Dawen Guo; Yuhong Pan; Yuling Xiao; Na Yue; Jonathan Hon-Kwan Chen; Susanna Kar-Pui Lau; Yingchun Xu; Patrick Chiu-Yat Woo
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

3.  Vaginal colonisation by Candida lipolytica.

Authors:  B Rajagopalan; M S Mathews; M Jacob
Journal:  Genitourin Med       Date:  1996-04

4.  Recurrent self-limited fungemia caused by Yarrowia lipolytica in a patient with acute myelogenous leukemia.

Authors:  C L Chang; T H Park; E Y Lee; Y T Lim; H C Son
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

5.  Catheter-related candidemia caused by Candida lipolytica in a patient receiving allogeneic bone marrow transplantation.

Authors:  Domenico D'Antonio; Ferdinando Romano; Eugenio Pontieri; Giuseppe Fioritoni; Claudia Caracciolo; Stefano Bianchini; Paola Olioso; Tommaso Staniscia; Roberta Sferra; Stefania Boccia; Antonella Vetuschi; Giovanni Federico; Eugenio Gaudio; Giuseppe Carruba
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

6.  Properties of a rat monoclonal antibody reactive with both the mannan of Candida species and the O-antigen 6,7 polysaccharide of serogroup C1 salmonellae.

Authors:  N A Nnalue; A Weintraub; A A Lindberg
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

Review 7.  New and emerging yeast pathogens.

Authors:  K C Hazen
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

8.  Fungemia caused by Yarrowia lipolytica.

Authors:  H Trabelsi; K Chtara; N Khemakhem; S Néji; F Cheikhrouhou; H Sellami; R Guidara; F Makni; M Bouaziz; A Ayadi
Journal:  Mycopathologia       Date:  2015-01-23       Impact factor: 2.574

9.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.